查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587308

商業生物技術分離系統市場：依方法、應用分類 - 2025-2030 年全球預測

Commercial Biotechnology Separation Systems Market by Method (Conventional Methods, Modern Methods), Application (Agriculture, Biopharmaceutical, Cosmetics & Personal Care) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

商業生物技術分離系統市場2023年估值為265.5億美元，預計到2024年將達到296.5億美元，複合年成長率為12.14%，到2030年將達到592.4億美元，預計將達到1000萬美元。

商業生物技術分離系統市場包括旨在從複雜混合物中分離生物分子、細胞和顆粒的技術和工藝，可應用於製藥、實驗室和工業生物加工。該領域的成長是由於對生物製藥的需求不斷成長、基因組學和蛋白​​質組學的進步以及對高純度生技藥品的需求不斷成長而推動的。關鍵技術包括離心、膜過濾、層析法和電泳，廣泛應用於藥物發現、蛋白質回收和細胞培養過程。生物技術的應用不斷擴大，醫學、農業和環境管理成為重要的最終用途。慢性疾病的日益普及需要創新的治療方案，以及在農業中擴大使用生物技術來提高作物產量是關鍵的成長動力。政府對研發的投資不斷增加，加上個人化醫療和生物療法的日益普及，為市場參與企業提供了利潤豐厚的機會。然而，高昂的初始設置成本、困難的法規環境以及與處理先進分離系統相關的技術複雜性等挑戰構成了巨大的障礙。儘管如此，這個市場仍顯示出充足的創新潛力，特別是在整合人工智慧以提高系統效率、開拓具有成本效益的解決方案和最佳化分離流程方面。專注於新型生物相容性材料和可擴展系統的研究探索的時機已經成熟。競爭格局的特點是快速的技術進步和旨在提高效率和擴大產品系列的策略聯盟。企業應注重技術創新和策略聯盟，以鞏固市場地位。透過開拓經濟實惠、靈活且可靠的生物製程系統來釋放重要的市場機會，這些系統可支援可擴展性，同時確保符合監管標準。擴展這些技術以跟上世界生物技術應用的激增對於持續成長至關重要，而針對監管要求的適應性方法可能有助於緩解潛在的挑戰。畢竟，市場格局是動態的，成長取決於持續創新和快速適應不斷變化的市場需求。

主要市場統計
基準年[2023] 265.5億美元
預測年份 [2024] 296.5億美元
預測年份 [2030] 592.4億美元
複合年成長率（%） 12.14%

市場動態：揭示快速發展的商業生物技術分離系統市場的關鍵市場洞察

商業生物技術分離系統市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 對個人化藥物和細胞療法的需求不斷成長
    • 政府研發經費增加
    • 在塑膠和化學品的商業生產中擴大採用磁力分離器
  • 市場限制因素
    • 與商業生物技術分離系統相關的高成本
  • 市場機會
    • 商業生物技術分離系統的不斷進步
    • 政府為中小企業採用新技術提供財政支持
  • 市場問題
    • 產品品質監管要求嚴格的問題

波特五力：引領商業生物技術分離系統市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解商業生物技術分離系統市場的外部影響

外部宏觀環境因素在塑造商業生物技術分離系統市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解商業生物技術分離系統市場的競爭格局

對商業生物技術分離系統市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣商業生物技術分離系統市場供應商的績效評估

FPNV 定位矩陣是評估商業生物技術分離系統市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃商業生物技術分離系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對商業生物技術分離系統市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對個人化藥物和細胞治療方法的需求不斷成長
      • 增加政府對研究和開發的資助
      • 在塑膠和化學品的商業生產中擴大採用磁力分離器
    • 抑制因素
      • 與商業生物技術分離系統相關的高成本
    • 機會
      • 商業生物技術分離系統的不斷進步
      • 政府為中小企業採用新技術提供財政支持
    • 任務
      • 產品品質嚴格監管要求相關問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章商業生物技術分離系統市場：依方法

  • 介紹
  • 常規方法
    • 離心
    • 層析法
    • 電泳
    • 流式細胞技術
    • 薄膜過濾
  • 現代方法
    • 生物晶片
    • 實驗室晶片
    • 磁選
    • 微陣列

第7章商業生物技術分離系統市場：依應用

  • 介紹
  • 農業
  • 生物製藥
  • 化妝品/個人護理
  • 飲食

第8章美洲商業生物技術分離系統市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太商業生物技術分離系統市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲商業生物技術分離系統市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • GE HealthCare Technologies Inc.
  • GL Sciences Inc.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • JASCO International Co., Ltd.
  • LECO Corporation
  • Luminex Corporation by DiaSorin SpA
  • Merck KGaA
  • Miltenyi BIoTec BV & Co. KG
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • QIAGEN NV
  • Repligen Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Waters Corporation
Product Code: MRR-521BAA36EA74

The Commercial Biotechnology Separation Systems Market was valued at USD 26.55 billion in 2023, expected to reach USD 29.65 billion in 2024, and is projected to grow at a CAGR of 12.14%, to USD 59.24 billion by 2030.

The commercial biotechnology separation systems market encompasses technologies and processes designed to isolate biological molecules, cells, or particles from complex mixtures, instrumental for applications in pharmaceuticals, research laboratories, and industrial bioprocessing. This sector's growth is driven by an increasing demand for biopharmaceuticals, advancements in genomics and proteomics, and the rising need for high-purity biological products. Key technologies include centrifugation, membrane filtration, chromatography, and electrophoresis, utilized extensively across drug discovery, protein recovery, and cell culture processes. Biotechnological applications continue to expand, with healthcare, agriculture, and environmental management emerging as significant end-uses. The growing prevalence of chronic diseases, necessitating innovative treatment options, alongside expanding biotechnological applications in agriculture for improved crop yield, are pivotal growth drivers. The rise in government investments in research and development, paired with the escalating adoption of personalized medicine and biological therapies, offers favorable opportunities for market players. However, challenges such as high initial setup costs, stringent regulatory environments, and technical complexities associated with handling advanced separation systems pose significant barriers. Nonetheless, this market presents ample innovation potential, particularly in enhancing system efficiencies, developing cost-effective solutions, and integrating AI for optimizing separation processes. Research focused on novel biocompatible materials and scalable systems are ripe for exploration. The competitive landscape is characterized by rapid technological advancements and strategic collaborations targeting increased efficiency and expanded product portfolios. Businesses should focus on technological innovation and strategic partnerships to bolster their market position. Developing affordable, flexible, and reliable bioprocessing systems addressing scalability while ensuring compliance with regulatory standards can unlock substantial market opportunities. Scaling these technologies to meet the global surge in biotechnology applications will be crucial for enduring growth, while an adaptive approach towards regulatory requirements will mitigate potential challenges. Ultimately, the landscape is dynamic, with growth contingent upon continued innovation and responsive adaptation to evolving market needs.

KEY MARKET STATISTICS
Base Year [2023] USD 26.55 billion
Estimated Year [2024] USD 29.65 billion
Forecast Year [2030] USD 59.24 billion
CAGR (%) 12.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for personalized medicines and cell-based therapies
    • Rise in funding by the government for research and development
    • Expanding adoption of magnetic separators for commercial production of plastics and chemicals
  • Market Restraints
    • High cost associated with commercial biotechnology separation systems
  • Market Opportunities
    • Ongoing advancements in commercial biotechnology separation systems
    • Government provides financial assistance to SMEs to introduce novel technologies
  • Market Challenges
    • Problems regarding stringent regulation requirements for product quality

Porter's Five Forces: A Strategic Tool for Navigating the Commercial Biotechnology Separation Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Commercial Biotechnology Separation Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Commercial Biotechnology Separation Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Commercial Biotechnology Separation Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Commercial Biotechnology Separation Systems Market

A detailed market share analysis in the Commercial Biotechnology Separation Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Commercial Biotechnology Separation Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Commercial Biotechnology Separation Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Commercial Biotechnology Separation Systems Market

A strategic analysis of the Commercial Biotechnology Separation Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Commercial Biotechnology Separation Systems Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, GE HealthCare Technologies Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO International Co., Ltd., LECO Corporation, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novasep Holding SAS, PerkinElmer Inc., QIAGEN N.V., Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Commercial Biotechnology Separation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Conventional Methods and Modern Methods. The Conventional Methods is further studied across Centrifugation, Chromatography, Electrophoresis, Flow cytometry, and Membrane filtration. The Modern Methods is further studied across Biochip, Lab-on-a-chip, Magnetic separation, and Microarray.
  • Based on Application, market is studied across Agriculture, Biopharmaceutical, Cosmetics & Personal Care, and Food & Beverage.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicines and cell-based therapies
      • 5.1.1.2. Rise in funding by the government for research and development
      • 5.1.1.3. Expanding adoption of magnetic separators for commercial production of plastics and chemicals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with commercial biotechnology separation systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in commercial biotechnology separation systems
      • 5.1.3.2. Government provides financial assistance to SMEs to introduce novel technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Problems regarding stringent regulation requirements for product quality
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Commercial Biotechnology Separation Systems Market, by Method

  • 6.1. Introduction
  • 6.2. Conventional Methods
    • 6.2.1. Centrifugation
    • 6.2.2. Chromatography
    • 6.2.3. Electrophoresis
    • 6.2.4. Flow cytometry
    • 6.2.5. Membrane filtration
  • 6.3. Modern Methods
    • 6.3.1. Biochip
    • 6.3.2. Lab-on-a-chip
    • 6.3.3. Magnetic separation
    • 6.3.4. Microarray

7. Commercial Biotechnology Separation Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Agriculture
  • 7.3. Biopharmaceutical
  • 7.4. Cosmetics & Personal Care
  • 7.5. Food & Beverage

8. Americas Commercial Biotechnology Separation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Commercial Biotechnology Separation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Commercial Biotechnology Separation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alfa Laval AB
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Danaher Corporation
  • 7. GE HealthCare Technologies Inc.
  • 8. GL Sciences Inc.
  • 9. Hitachi, Ltd.
  • 10. Illumina, Inc.
  • 11. JASCO International Co., Ltd.
  • 12. LECO Corporation
  • 13. Luminex Corporation by DiaSorin S.p.A.
  • 14. Merck KGaA
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Novasep Holding SAS
  • 17. PerkinElmer Inc.
  • 18. QIAGEN N.V.
  • 19. Repligen Corporation
  • 20. Sartorius AG
  • 21. Shimadzu Corporation
  • 22. Thermo Fisher Scientific Inc.
  • 23. Tosoh Corporation
  • 24. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023